This article is more than 5 years old. Information may no longer be current.
Cardiology Today's Intervention's top 5 stories in April
Cardiology Today’s Intervention has compiled a list of the top 5 stories posted in April. This month, our readers were most interested in FDA announcements regarding renal denervation trials and heart pumps with optical sensors, a trial comparing novel oral anticoagulants and LAA closure, predictors of acute aortic dissection diagnosis and the future of interventional cardiology.
New renal denervation trial for hypertension greenlighted by FDA
Medtronic announced that the FDA has issued an investigational device exemption allowing the company to begin a randomized, sham-controlled pivotal trial to evaluate a renal denervation system in patients with hypertension.
Heart pump with optical sensor receives FDA approval
Abiomed announced that its new heart pump with an optical sensor has received premarket approval from the FDA for treatment of patients with cardiogenic shock.
According to a press release from the company, the heart pump (Impella CP with SmartAssist) is designed to reduce procedure time by using advanced software and optical sensors to improve positioning for the pump and allowing for repositioning without the need for imaging equipment.
Experts compare novel oral anticoagulants with LAA closure in AF
SAN DIEGO — In the era of novel oral anticoagulants and the availability of devices for left atrial appendage closure, combining the two treatments may offer a better approach to reducing the risk for stroke in patients with atrial fibrillation.
During a debate at the Society for Cardiovascular Angiography and Interventions Scientific Sessions, two experts discussed the benefits and risks of using oral anticoagulants or LAA closure in detail.
Predictors of acute aortic dissection diagnosis identified
Aortic aneurysm and hypotension were among the clinical features identified as putting patients at high risk for acute aortic dissection in a case-control study.
Robert Ohle, MSc, MA, MB, FRCPC, from the department of emergency medicine, the Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada, and colleagues conducted a historical matched case-control study of adults presenting to two tertiary care EDs or one regional cardiac referral center with possible acute aortic dissection between 2002 and 2014.
Interventional cardiology ‘at a pivot point’
SAN DIEGO — The field of interventional cardiology “has a very bright future,” Anthony N. DeMaria, MD, told the audience during the Hildner lecture at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Today, “interventional cardiology is at a pivot point. ... I see interventional cardiologists as standing their stronghold and expanding their role into multiple other areas,” DeMaria, the Jack and Judith White chair of cardiology at the University of California, San Diego, said here.